Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Calidi Biotherapeutics (CLDI) has shared an announcement.
Calidi Biotherapeutics, Inc. successfully raised approximately $6.1 million through a public offering of Common Stock Units and Pre-Funded Warrant Units at $0.40 each. This strategic move, aimed at bolstering the company’s financial position, involved various types of warrants with different exercise prices and expiration dates. The offering was completed with the assistance of Ladenburg Thalmann & Co., which served as the exclusive placement agent and received compensation for its role. The company has also planned a shareholder meeting to seek approval for a reverse stock split, demonstrating its proactive approach to corporate governance and financial management.
Find detailed analytics on CLDI stock on TipRanks’ Stock Analysis page.